Clinical Trials
3,807 trialsClinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
National Institutes of Health Clinical Center (CC)
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
National Institutes of Health Clinical Center (CC)
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
National Institutes of Health Clinical Center (CC)
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
National Institutes of Health Clinical Center (CC)
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
PALOMA
Janssen Research & Development, LLC
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Nemours Children's Clinic
A Study of JNJ-87890387 for Advanced Solid Tumors
Janssen Research & Development, LLC
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Johnson & Johnson Enterprise Innovation Inc.
OASIS1
Medical University of South Carolina
LUCERNA
Astellas Pharma Inc
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
A Study of JNJ-1761981 in Participants With Solid Tumors
Johnson & Johnson Enterprise Innovation Inc.
Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer
Children's Hospital Los Angeles
MK-9999-01D
Merck Sharp & Dohme LLC
LIFE Cancer Survivorship Database for Pediatric Cancer
Children's Hospital Los Angeles
RADIANT
University Health Network, Toronto
Rare Tumors and Cancer Predisposition in Individuals and Families
National Institutes of Health Clinical Center (CC)
Distraction-Based Interventions During Implanted Venous Port Catheter Needle Entry: Virtual Reality Application
Uludag University
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation
Bayer
Yoga to Improve Disparities in Cancer Survivorship
University of California, San Francisco
FACTOR
Canadian Cancer Trials Group
EROS
Eastern Cooperative Oncology Group
Pan Tumor Rollover Study
Bristol-Myers Squibb
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Ann & Robert H Lurie Children's Hospital of Chicago
COMPRENDO
University of California, San Diego
Development and Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Merck Sharp & Dohme LLC
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
Case Comprehensive Cancer Center
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
Nanfang Hospital, Southern Medical University
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Celgene
Patient Navigation 2.0
Northwestern University
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Alliance for Clinical Trials in Oncology
EORTC
Sohag Oncology Center
Data Collection, Clinical Care and Interventions in CCR, NCI
National Institutes of Health Clinical Center (CC)
Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
National Institutes of Health Clinical Center (CC)
Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer
City of Hope Medical Center
Connect for Cancer Prevention Study (Connect)
National Institutes of Health Clinical Center (CC)
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
EXERCADOL
Universidad Europea de Madrid
CaVe
Entia Ltd
REACT
Inland Norway University of Applied Sciences
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
AstraZeneca
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
Thomas Jefferson University
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Daiichi Sankyo
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Sanofi
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)